Kamp Pharmaceuticals

KAMP Pharmaceuticals is a specialty pharmaceutical company headquartered in Bridgewater, New Jersey, dedicated to the development of value-added medicines. The company primarily utilizes the FDA's 505(b)(2) regulatory pathway to create improved versions of existing therapeutic agents, focusing on enhancing drug delivery, safety, and patient compliance. KAMP's internal pipeline includes several proprietary programs targeting acute pain, critical care, and oncology. Led by industry veteran Kartik Mehta, the firm leverages deep expertise in formulation science and complex injectables to address significant unmet needs in the healthcare market. By optimizing the delivery and efficacy of established molecules, KAMP aims to provide enhanced treatment options for patients and healthcare providers while reducing development risks.